# Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome

> **NCT03468465** · PHASE4 · UNKNOWN · sponsor: **Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia** · enrollment: 110 (estimated)

## Conditions studied

- Urinary Incontinence

## Interventions

- **DRUG:** Solifenacin Succinate
- **DEVICE:** Neuro-Muscular Stimulators (NMS)

## Key facts

- **NCT ID:** NCT03468465
- **Lead sponsor:** Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-04
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2018-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03468465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03468465, "Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03468465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*